Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Stomatitis 2Neoplasms 2Thromboembolism 1Sarcoma 1Respiratory Insufficiency 1Prostatic Neoplasms 1Pneumonia 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Myocardial Infarction 1Mucositis 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Head and Neck Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Adenocarcinoma 1Acute Coronary Syndrome 1

Interventions

Cytarabine 272Cyclophosphamide 136fludarabine phosphate 127Azacitidine 117Peripheral Blood Stem Cell Transplantation 95Busulfan 93Filgrastim 80Decitabine 79fludarabine 78Mycophenolic Acid 78Idarubicin 76Etoposide 76Whole-Body Irradiation 75Daunorubicin 72Tacrolimus 71Cyclosporine 64Methotrexate 62Mitoxantrone 57Clofarabine 55Antilymphocyte Serum 55Granulocyte Colony-Stimulating Factor 51Gemtuzumab 50Melphalan 49venetoclax 48Radiotherapy 30sargramostim 28Injections 25Bortezomib 25thymoglobulin 24aldesleukin 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Acute × Sodium Bicarbonate × Clear all
NCT04321161 2020-03-25

Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment

University of Freiburg

Phase EARLY_PHASE1 Completed
10 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡